Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-05

Clinical Trial Update: Sufentanil Intranasal [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for intranasal sufentanil in emergencies and acute pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sufentanil (intranasal) (sufentanil)

Snippet

Sponsor: Centre Hospitalier Universitaire Saint Pierre | Conditions: Emergencies, Pain, Acute | Phase 4 | Status: UNKNOWN